We divided the 165 ES‐SCLC patients in the chemo‐immune group into the PD‐1 subgroup (n = 91) and PD‐L1 subgroup (n = 74) according to the choice of ICIs. This evidence concerns the gene CD274 and small cell lung carcinoma.